156 related articles for article (PubMed ID: 21726591)
1. Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model.
Nojima J; Maeda A; Aoki S; Suo S; Yanagihara D; Watanabe Y; Yoshida T; Ishiura S
Vaccine; 2011 Aug; 29(37):6252-8. PubMed ID: 21726591
[TBL] [Abstract][Full Text] [Related]
2. Production of anti-amyloid β antibodies in mice fed rice expressing amyloid β.
Nojima J; Ishii-Katsuno R; Futai E; Sasagawa N; Watanabe Y; Yoshida T; Ishiura S
Biosci Biotechnol Biochem; 2011; 75(2):396-400. PubMed ID: 21307566
[TBL] [Abstract][Full Text] [Related]
3. Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model.
Mouri A; Noda Y; Hara H; Mizoguchi H; Tabira T; Nabeshima T
FASEB J; 2007 Jul; 21(9):2135-48. PubMed ID: 17341681
[TBL] [Abstract][Full Text] [Related]
4. Active immunization of mice with an Abeta-Hsp70 vaccine.
Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
[TBL] [Abstract][Full Text] [Related]
5. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
[TBL] [Abstract][Full Text] [Related]
6. Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination.
Ishii-Katsuno R; Nakajima A; Katsuno T; Nojima J; Futai E; Sasagawa N; Yoshida T; Watanabe Y; Ishiura S
Biochem Biophys Res Commun; 2010 Sep; 399(4):593-9. PubMed ID: 20682291
[TBL] [Abstract][Full Text] [Related]
7. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
[TBL] [Abstract][Full Text] [Related]
8. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J
Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870
[TBL] [Abstract][Full Text] [Related]
9. Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer's disease mouse model.
Youm JW; Kim H; Han JH; Jang CH; Ha HJ; Mook-Jung I; Jeon JH; Choi CY; Kim YH; Kim HS; Joung H
FEBS Lett; 2005 Dec; 579(30):6737-44. PubMed ID: 16310782
[TBL] [Abstract][Full Text] [Related]
10. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.
Petrushina I; Davtyan H; Hovakimyan A; Davtyan A; Passos GF; Cribbs DH; Ghochikyan A; Agadjanyan MG
Mol Ther; 2017 Jan; 25(1):153-164. PubMed ID: 28129111
[TBL] [Abstract][Full Text] [Related]
12. Transgenic rice expressing amyloid β-peptide for oral immunization.
Yoshida T; Kimura E; Koike S; Nojima J; Futai E; Sasagawa N; Watanabe Y; Ishiura S
Int J Biol Sci; 2011 Mar; 7(3):301-7. PubMed ID: 21448341
[TBL] [Abstract][Full Text] [Related]
13. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice.
Xing XN; Zhang WG; Sha S; Li Y; Guo R; Wang C; Cao YP
Chin Med J (Engl); 2011 Sep; 124(17):2636-41. PubMed ID: 22040416
[TBL] [Abstract][Full Text] [Related]
14. [Current trend of immunotherapy for Alzheimer's disease].
Matsumoto SE; Tabira T
Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of a fusion protein between the cholera toxin B subunit and the 42-amino acid isoform of amyloid-β peptide produced in silkworm pupae protects against Alzheimer's disease in mice.
Li S; Wei Z; Chen J; Chen Y; Lv Z; Yu W; Meng Q; Jin Y
PLoS One; 2014; 9(12):e113585. PubMed ID: 25469702
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576.
Chauhan NB; Siegel GJ
J Neurosci Res; 2003 Oct; 74(1):142-7. PubMed ID: 13130516
[TBL] [Abstract][Full Text] [Related]
17. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
Xing X; Sha S; Li Y; Zong L; Jiang T; Cao Y
J Neurol Sci; 2012 Feb; 313(1-2):17-21. PubMed ID: 22029939
[TBL] [Abstract][Full Text] [Related]
20. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN
Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
